Cowen Downgrades Nivalis Therapeutics (NVLS) to Market Perform

November 29, 2016 7:38 AM EST
Get Alerts NVLS Hot Sheet
Price: $2.09 -5.43%

Rating Summary:
    1 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade NVLS Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Cowen downgraded Nivalis Therapeutics (NASDAQ: NVLS) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Nivalis Therapeutics click here. For more ratings news on Nivalis Therapeutics click here.

Shares of Nivalis Therapeutics closed at $6.25 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Cowen & Co

Add Your Comment